The world is in urgent need of new antibiotics because bacteria are becoming resistant to existing drugs. This article (in German only) looks at the innovation gap that is posing a threat to global public health, and the solutions, including the CARB-X partnership, that have emerged to help develop new antibiotics to treat these drug-resistant bacteria. Der Spiegel Wissen